Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] After the average performance for FY21 and FY22 (standalone basis), it marked miraculous profits for FY23 on a standalone and consolidated basis. This not only raises eyebrows, but concerns over the sustainability going forward. One more surprise is the hike in the issue size in just a few days as can be seen from RHP dated 01.05.23 and 06.05.23. Considering this, the issue lacks transparency and is aggressively priced discounting all near-term positives. There is no harm in skipping this pricey IPO. Read detail review...
Auro Impex IPO Reviews, analysis and views by popular members. Read Auro Impex & Chemicals Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: